The government of The United States reported that it will allow the entry of people whose vaccination schedule with different types of drugs, which are approved by the World Health Organization (WHO). Which will apply from November 8.
The foregoing was confirmed by the US Centers for Disease Control and Prevention (CDC) and its spokesperson indicated that the “people who have a combination of two (different) doses of a dual-dose vaccine that has been licensed by the Food and Drug Administration (FDA, for its acronym in English or is on the WHO emergency use list, vaccines with the full schedule will be considered ”.
The CDC has not recommended mixing biologics in a primary series, he specified, “we recognize that this is increasingly common in other nations, so it should be accepted for the interpretation of vaccination tests.”
The vaccines that the WHO has authorized by the FDA:
- Pfizer / BioNTech
- Janssen (from Johnson & Johnson)
While the vaccines that are not listed were Sputnik V and CanSino, which were administered in Mexico. President Andrés Manuel López Obrador has asked the WHO to speed up the process to include vaccines on the emergency list.
WHO announced on October 12 that could approve the Russian drug by the end of 2021.
Soumya Swaminathan, chief scientist of this body, said in an interview with the RIA Novosti agency: “There are some legal documents that must be signed by both parties before the process continues.”
Although the organization did not give a date in this regard, it specified that if the documents are signed in the next few days, the evaluation will resume, “it is highly probable that the inspection will also take place until the end of the year and the process may be completed.”
The US government reported that on November 8 it will open its air and land borders to foreigners, who must have a complete vaccination scheme.
Continue reading: Young people from 18 to 29 years old will receive a second dose against Covid-19 in these 5 mayors of the CDMX
Covid-19: Sputnik V vaccine could be approved by WHO in late 2021
The G20 promotes distribution of vaccines against COVID-19 to developing nations